about
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patientsArtificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.Phospholipase D is a target for inhibition of astroglial proliferation by ethanol.Dysfunctional Presynaptic M2 Receptors in the Presence of Chronically High Acetylcholine Levels: Data from the PRiMA Knockout Mouse.Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.Quantitative determination of acetylcholine and choline in microdialysis samples by MALDI-TOF MS.Fast quantitative determination of methylphenidate levels in rat plasma and brain ex vivo by MALDI-MS/MS.Molecular rationale for the pharmacological treatment of Alzheimer's disease.Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides.Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?Pathophysiological amyloid concentrations induce sustained upregulation of readthrough acetylcholinesterase mediating anti-apoptotic effects.Selective enhancement of the activity of C-terminally truncated, but not intact, acetylcholinesterase.Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.Integrating medical humanities into a pharmaceutical care seminar on dementia.Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition.Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.Enhanced student experience: an analysis of subjective evaluation and objective learning success after the transformation of a pharmaceutical physiology course.Fictional and real-world revolutionary heroes in the history of psychiatric politics.Narrating stroke: the life-writing and fiction of brain damage.Dementia in life writing: our health care system in the words of the sufferer.Literature and science: a different look inside neurodegeneration.Uptake of lithium into rat brain after acute and chronic administration.Case studies in a physiology course on the autonomic nervous system: design, implementation, and evaluation.Dynamics of hippocampal acetylcholine release during lithium-pilocarpine-induced status epilepticus in rats.Deliver us from evil: carer burden in Alzheimer's disease.Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
P50
Q24676332-0DC426BB-268C-4BFE-99E9-3F9CCB95A6EDQ24811064-C53E67D7-4CC4-4834-9F84-809DC8C89C54Q30968562-C8B7D218-13CE-4166-A05E-8135B4143AD9Q31011918-980FA56D-1937-47E1-BAEE-2CBDEF4F4035Q33418312-65EE3E75-BE1E-4CB5-B0C2-C6A71C3FA7C8Q33522686-ADAABF7B-CB7E-49C6-A0EA-9CC9B8460994Q36321707-AECD0AA1-A684-4351-AFC7-0FB50D444F55Q36408857-0EEEEC08-5FC5-4650-88C3-EA6184CDB4F6Q37060542-E8490863-152E-47F4-988F-EE5D1B40CE41Q38132755-AE232109-EDBD-469D-B9A3-0A4DAB8565DBQ39181641-0E48ABC3-B3F9-413E-BA27-FFE67FBB5067Q40156490-155AD10A-D582-4978-B663-481100E32BEEQ40520119-509430AD-C541-4812-9818-B01FD9214BDCQ41907913-8B015BE6-2A13-41DA-9A52-944E3D9FB04EQ44761930-CFCA9BEA-E19C-4A4C-B0AE-5DB5D8954D25Q45816185-956165ED-82DA-43A6-BBED-48A52725780AQ47356703-B13EF830-7E47-4620-B2A9-58CC92896C1EQ47977811-F535EEAB-DB5A-4DEE-AABC-658389F6552EQ48222508-C6FA9870-F0F7-473B-89EF-D4ACDF30FCA7Q48348110-BDF44771-CD70-4B9C-81F3-B71218F81719Q48422145-321FB7BF-E725-45FB-B3E3-BD75A0B8E8DDQ48450927-B6B63393-4ABC-46C4-8F73-4989F3667909Q48474389-A6149090-3B7B-45BA-97C0-9EB63E5BDC4FQ48485700-C014A54A-AA94-42FF-AAED-899262F1DF58Q48544048-494B9723-0941-43B8-AFE1-B6FF1D2C0BFAQ48726384-EDF95544-5A93-4041-B658-19E76F7C0D55Q53046044-FBE0EDE4-4024-4650-9660-55F466CFE97EQ53370360-C1C66942-4E16-450D-B691-93EFB16F3F6F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martina Zimmermann
@ast
Martina Zimmermann
@en
Martina Zimmermann
@es
Martina Zimmermann
@sl
type
label
Martina Zimmermann
@ast
Martina Zimmermann
@en
Martina Zimmermann
@es
Martina Zimmermann
@sl
prefLabel
Martina Zimmermann
@ast
Martina Zimmermann
@en
Martina Zimmermann
@es
Martina Zimmermann
@sl
P106
P21
P31
P496
0000-0003-4274-6145